Safely protecting
against mosquito-borne
viral diseases

Mosquito-borne pandemic threats are rising all over the world due to climate change and human-led environmental impact

500 mil

Infections per year

> 100 K

Annual deaths

€9 bil

Economic loss

1 flavivaccine

Discover our solution

We are developing a novel vaccination approach to prepare for future emerging epidemics or pandemics caused by flaviviruses.

About

Flavivaccine encompasses the entire research and development process to create a safe and cost-effective vaccine against multiple flaviviruses.

Flavivirus

The public health threat from flaviviruses is becoming increasingly serious worldwide, making urgent and effective protection against them essential.

Last updates

project update - April 21, 2026

Progress and next steps: FLAVIVACCINE General Assembly in Fontenay-aux-Roses

Last week, the FLAVIVACCINE consortium gathered in Fontenay-aux-Roses (France) for the project’s latest General Assembly, kindly hosted by CEA.

project update - October 6, 2025

FLAVIVACCINE Consortium held General Assembly to review project’s progress and next steps

The FLAVIVACCINE consortium held its General Assembly online on September 30 and October 2, bringing together partners from across Europe and the U.S. to reflect on recent progress and plan the next steps in the project.

project update - October 3, 2025

FLAVIVACCINE represented at The European Researchers’ Night in Portugal

European Researchers' Night took place on 26 September 2025. The event is promoted by the European Commission through the Marie Skłodowska-Curie Actions. FLAVIVACCINE was represented in Portugal.

News & Events

Subscribe to the
newsletter